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Abstract
Background: Physical activity (PA) is positively associated with quality of life. People with a stoma are less likely to
engage in PA than those without a stoma.
Methods: In this feasibility intervention study, we will perform the following: (1) Develop a PA intervention for people
with a stoma. An Expert Working Group of behavioural scientists, exercise scientists, clinicians and a Patient Advisory
Group of people with a bowel stoma will meet with the research team to inform the development of a PA intervention
for people with a stoma. A manual of the intervention will be the main output. (2) Explore PA instructors’ experiences of
delivering the PA intervention. PA instructors will record on paper the number of PA consultations with each patient and
a researcher will interview the PA instructors about their experiences of delivering the intervention. (3) Assess the level of
patient (bowel cancer or inflammatory bowel disease (IBD) patients with a stoma between 6 weeks and 24months post-
surgery) engagement with the PA intervention and their views on intervention acceptability and usefulness. Patients will
keep a PA diary to record daily pedometer recorded step count and type and duration of activities. A researcher will
interview patients about their experiences of the PA intervention. (4) Assess screening, eligibility, consent, data
completion, loss to follow up, and missing data rates, representativeness of participants and potential treatment effects.
A researcher will record on paper all study procedure parameters. Quality of life (stoma-quality of life; Functional
Assessment of Cancer Therapy, Short IBD questionnaire), fatigue (FACIT fatigue scale) and PA (accelerometer) will be
measured pre- and post-intervention in patients. For IBD patients only, blood will be taken to measure systemic
inflammation.
Discussion: We hypothesise that a PA intervention will be an effective means of improving the quality of life of people
with a stoma. Before embarking on a full randomised controlled trial to test this hypothesis, a PA intervention needs to
be developed and a feasibility study of the proposed PA intervention conducted.
Trial registration: ISRCTN58613962, Protocol version: 0.1. 14 September 2017.
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Background
This article presents a research protocol for a feasibility
study of a physical activity (PA) intervention to improve
the quality of life in patients with a bowel stoma. The
Standard Protocol Items: Recommendations for Inter-
ventional Trials (SPIRIT) checklist for reporting inter-
vention trial protocols has been used for guidance [1].
A stoma is an artificial opening on the surface of the
abdomen that has been surgically created in order to
divert the flow of faeces or urine [2]. The two types of
eliminating bowel stomas are colostomy and ileostomy,
which can be temporary or permanent [2]. In Europe,
approximately 700,000 people are living with a stoma,
and in the USA, more than 1 million people have a
stoma [3]. It is estimated that there are 100,000 people
with stomas in the UK [4]. There are a number of condi-
tions that may necessitate the formation of a bowel
stoma including bowel cancer and inflammatory bowel
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disease (IBD) [2]. Recent systematic reviews suggest that a
stoma has a negative impact on quality of life [5–7]. Re-
search about lived experiences and psychosocial health
following stoma formation highlights three key themes:
psychosocial impact around feeling of loss of control of
body function, physical aspects that affect psychological
function and quality of life and the process of acceptance,
adaptation and adjustment [8]. A systematic review of 11
qualitative studies about people’s experiences of bodily
change following stoma formation suggests that people
experience profound disruptions in how their body looks,
functions, sounds, smells and feels [9]. Interventions are
therefore needed that have the potential to improve the
quality of life for this group of patients.
PA has been identified by patients with a stoma as a
research priority in relation to their quality of life [10]. A
recent systematic review found that PA was positively asso-
ciated with quality of life in long-term (≥ 5 years post diag-
nosis) bowel cancer survivors [11]. Additionally, emerging
evidence suggests an association between PA and quality
of life in people with IBD [12]. Yet, in bowel cancer survi-
vors, those with a stoma are less likely to engage in PA
than those without a stoma (odds ratio (OR) = 1.51, 95%
confidence interval (CI) = 1.12–2.04) [13]. Furthermore,
two recent surveys found that people with a stoma report
reductions in PA following stoma formation [14, 15]. To
address low levels of PA, there is a need to develop PA
interventions specifically for people with a stoma.
Methods
Aim
We hypothesise that a PA intervention will be an effective
means of improving the quality of life of people with a
stoma. Before embarking on a full randomised controlled
trial to test this hypothesis, a PA intervention needs to be
developed and a feasibility study of the proposed PA inter-
vention conducted. The main focus of this study is feasi-
bility and acceptability of intervention implementation
and study procedures for recruitment and measures of
treatment effects. The objectives of this feasibility study,
therefore, are as follows: (1) to develop a PA intervention
for people with a stoma; (2) to explore PA instructors’ ex-
periences of delivering the PA intervention; (3) to assess
the level of patient engagement with the PA intervention
and their views on intervention acceptability and useful-
ness; and (4) to assess screening, eligibility, consent, data
completion, loss to follow up, missing data rates, represen-
tativeness of participants and potential treatment effects.
Design
The research will draw on Stage I Development and Stage
II Feasibility and Piloting of the Medical Research Council
framework for the development of complex interventions
[16]. Stage 1 involves intervention development. In Stage 2,
the feasibility and acceptability of the intervention and trial
procedures will be assessed using a quasi-experimental
design, which will include measures of potential treatment
effects being taken pre- and post-intervention.
Stage 1: Intervention development
The research team already have an idea of what the
intervention will look like, which is based on their previ-
ous work with cancer patients, including people with
bowel cancer [17, 18]. Nonetheless, an Expert Working
Group of behavioural scientists, exercise scientists, clini-
cians and a Patient Advisory Group of people with a
bowel stoma will meet with the research team to inform
the development of a PA intervention for people with a
stoma. A manual of the intervention will be the main
output from Stage 1.
The plan is to develop an intervention so that people
with a bowel stoma are referred to a PA instructor, trained
by the research team, to prescribe and support people
with stoma engage in PA. Participants will undergo a
physical function and fitness test (6-min walk [19], 30-s
sit-to-stand test and chair sit-and-reach and arm-curl test
[20]), be offered weekly PA consultations for 12 weeks and
receive a pedometer to monitor their weekly PA in a diary
designed for the purposes of the study. The PA consulta-
tions will be individual, face-to-face or by video confer-
ence once a week for 12 weeks. To promote and sustain
behaviour change, consultations will incorporate core
behaviour change techniques (e.g. goal-setting) recom-
mended by the National Institute for Health and Care
Excellence [21].
Stage 2: Feasibility study
Setting
Participants will be recruited from three National Health
Service Trusts/Boards: NHS Highland (Scotland); London
North West Healthcare Trust; University College London
Hospitals NHS Foundation Trust.
Eligibility criteria
Inclusion
 Diagnosed with Stage I–IV bowel cancer OR
diagnosed with IBD;
 > 6 weeks and < 24 months since stoma formation
(permanent or temporary) surgery (laparoscopic or
open surgical procedure); and
 Willing and able to provide written informed
consent.
Exclusion
 Emergency surgery for stoma formation;
 Clinician recommends that the patient should not
engage in any type of PA; and
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 Ongoing adjuvant therapy (chemotherapy or
radiotherapy).
Main outcomes of the feasibility study
The main focus of this study is feasibility and acceptability
of intervention implementation and study procedures for
recruitment and measurement of treatment outcomes.
Assessing feasibility and acceptability of intervention
implementation The intervention will involve partici-
pants having 12 consultations with a PA instructor.
Intervention fidelity will be measured by the number of
consultations completed. PA instructors will record for
each participant the number of PA consultations, duration
and type (e.g. face-to-face, video call, telephone call). The
PA instructor will prescribe three types of physical
activity during each PA consultation for each week:
physical fitness/aerobic activities (e.g. walking, cycling,
swimming), muscular strengthening activities and mo-
bility and movement activities. The PA instructor will
recommend level of exertion for each type of activity
using the Borg RPE Scale [22].
Intervention adherence will be measured as the comple-
tion rate of the prescribed PA. The participant will write
down the three types of prescribed weekly activities in a
PA diary that they will complete for the 12-week duration.
Participants will record for each day their daily step count
from the pedometer. They will record how much of the
prescribed activity they managed that week using a con-
tinuous rating scale: all of it (100%), most of it (75%), some
of it (25%), and none of it (0%). Hence, intervention adher-
ence will be measured by the average completion rate of
the three different types of prescribed activities. They will
describe any additional physical activities they did during
the week, how they felt doing the prescribed activities (e.g.
challenges) and if they had any issues with their stoma.
The acceptability of the intervention will be explored
through semi-structured face-to-face or telephone inter-
views (depending on participant preference) with partici-
pants and PA instructors. A semi-structured interview is
chosen as it allows flexibility with sequencing of questions
and for following up on any topics that arise naturally
through discussion [23]. These interviews will last approxi-
mately 30min and cover participants’ and PA instructors’
opinions on perceived stoma-related barriers to PA, con-
tent of the PA intervention and its perceived relevance and
usefulness in addressing stoma-related barriers to being
physically active.
Assessing study procedures Screening, eligibility, con-
sent and data completion and loss to follow up rates and
reasons for excluding patients will be presented as per-
centages. Recruitment rates will be measured as rate of
invited participants who are eligible and consenting.
Clinical information including diagnosis (e.g. cancer or
IBD), surgery (e.g. open or laparoscopy), date of stoma
surgery, disease staging, stoma type (e.g. permanent or
temporary, ileostomy or colostomy) and demographic
information (e.g. age, sex) will be collected to assess rep-
resentativeness of participants. Suitability of measure-
ment procedures will be evaluated based on completion
rates and rates of missing data.
Other outcomes of the feasibility study
We will assess the feasibility and acceptability of the
proposed outcomes for a future randomised controlled
trial at baseline and follow-up. We will also estimate po-
tential treatment effects.
Quality of life Stoma-related quality of life (QoL) will
be measured using Stoma-QoL [24]. Nineteen items are
scored in relation to work/social function, sexuality/body
image, stoma function, financial concerns and skin irrita-
tion. Overall satisfaction with life is scored from 0 to
100, with a higher score indicating better QoL. To our
knowledge, no recommended minimal important differ-
ences (MIDs) have been published for this instrument.
Bowel cancer-related QoL will be measured using the
Functional Assessment of Cancer Therapy (FACT-C) [25].
The instrument includes general and colorectal cancer-
specific subscales. Thirty-seven items are scored in rela-
tion to physical, social, emotional and functional well-
being, and a specific section for colorectal cancer, and
stoma QoL. A higher score indicates better QoL. The rec-
ommended MIDs are 2–3 points for the colorectal cancer
subscale and 5–8 points for the FACT-C total score [26].
IBD-related QoL will be measured using the Short In-
flammatory Bowel Disease Questionnaire (SIBDQ) [27].
The instrument measures physical, social and emotional
status, with a higher score indicating better QoL. An evalu-
ation of the Patient-Reported Outcomes Measurement In-
formation System in a large cohort of patients with IBDs
recommended MIDs in the range of 2–6 points [28].
Fatigue Fatigue will be measured using the FACIT
Fatigue Scale, which is a short, 13-item questionnaire
that measures an individual’s level of fatigue during their
usual daily activities over the past week [29]. The score
range is 0–52, with a score of < 30 indicating fatigue.
The recommended MIDs are 3 points [30].
Physical activity The amount of PA will be objectively
measured using the Actigraph GT3X+ accelerometer
(Actigraph LLC, Pensacola, FL, USA) [31]. It will be worn
around the wrist and measures activity counts, steps, incli-
nometers and light and moderate to very vigorous PA.
Accelerometers record movement in such a way that it
can be translated into a number of different outputs, for
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example, total step count, bouts of PA at specified inten-
sities or energy expenditure. Accelerometer devices will be
initialised by a researcher as follows: (1) Device recording
of PA will be set for 7 days, with the intention to gain at
least 4 usable days of data for each participant (4 days is
standard practice). (2) The date and time when the partici-
pant is scheduled to wear the device will be set. The sample
rate will be set to 30Hz. (4) The unique participant ID will
be added to the specific device. Once the device is returned
by a participant, Actigraph software will be used to down-
load data as follows: (1) the unit of measurement will be set
at 10-s epochs; (2) the ‘# of axis’ setting will be set to 3; and
‘steps’, ‘lux’, ‘inclinometer’ and ‘low frequency extension’ will
all be selected. Actigraph software wear-time validation will
be set to meet the following criteria: (1) minimum number
of valid days required = 4, (2) non-wear-time will be set at
> 60min of consecutive zeros and (3) minimum number of
wear hours per day required will be set at > 10 h (600min).
Commonly accepted cut-off points for adults will be used
to differentiate PA intensity using Freedson et al. [31] adult
cut-off criteria: sedentary < 100 counts per minute, light
100–1951 counts per minute, moderate 1952–5724 counts
per minute and vigorous > 5725 counts per minute. In
addition, a sedentary bout will be set at 10min.
Inflammation Systemic inflammation is a marker of
IBD disease activity. Hence, only a sub-group of partici-
pants (i.e. those with IBD) will have their blood taken.
Inflammation will be measured by C-reactive protein, white
cell count, neutrophil count, platelet count and albumin.
As markers of inflammation, these laboratory results will
indicate any changes in inflammatory response in the
participant.
Participant timeline
Figure 1 illustrates the process of enrolling participants
in the study and timing of intervention and measure-
ments. Figure 2 displays the SPIRIT figure of enrol-
ments, interventions and assessments.
Sample size
It is inappropriate to base feasibility study sample sizes
on measures of intervention effect, which is the purpose
of the full-scale trial. Although how many participants
are required in a feasibility study remains equivocal, sug-
gestions range from 10 to 75 [32]. We aim to recruit 30
participants across three sites which should provide a
sample of participants with different demographic and
clinical characteristics that will improve our confidence
in the conclusions we draw from this feasibility study.
Recruitment
Three recruitment methods will be used and the number
of patients recruited by each method will be compared:
Prospective A stoma/colorectal nurse specialist will
discuss the study with eligible patients and, if they are
interested, will pass their contact details on to a member
of the research team. Verbal consent will be obtained. A
researcher will then contact the patient to organise a
face-to-face meeting where they will explain the study in
further detail and take informed consent from the
participant.
Retrospective A list of potentially eligible patients will
be put together by the clinical team. This list will be anon-
ymised by removing name and contact details so that a
member of the research team can re-assess patients for
eligibility. The clinical team will send a letter of invitation
to those that are eligible. Those that are interested will get
in touch with the research team so that eligibility can be
confirmed and to explain the study in more detail and take
informed consent.
Social media Recruitment via social media will also be
used to maximise recruitment numbers. An advertise-
ment about the study will be disseminated by members
of the Patient Advisory Group and by relevant stoma
charities on both Facebook and Twitter. Contact details
of the research team will be provided, along with brief
eligibility criteria. This will allow anyone who is inter-
ested in taking part to see if they will be eligible and to
contact the research team directly.
Data collection
Data to evaluate the main outcomes of the feasibility
study will be collected as follows: to collect data to
assess intervention implementation, PA instructors will
keep a paper record of each PA consultation with each
participant; to collect data to assess intervention adher-
ence, participants will complete a PA diary; and to
collect data to assess study procedures, researchers in
the three sites will keep records of recruitment parame-
ters (e.g. number of participants screened, consenting)
and completion of baseline and follow up measures.
Data to evaluate the other outcomes of the feasibility
study will be collected as follows: proposed outcome
measures for a future randomised controlled trial will be
collected twice immediately before and immediately after
the 12 week PA intervention. Each participant will meet
with a researcher face to face to complete questionnaires
(QoL and fatigue measures) hosted by Bristol Online Sur-
vey, which is an online service that allows researchers to
develop, deploy and analyse an online survey. Participants
with IBD only will have their blood taken by a nurse and
the researcher will send the sample to the hospital labora-
tory for testing. Participants will be given an accelerometer
that will be worn during waking hours for 7 consecutive
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days for 1 week. At the end of the 7-day period, participants
will return the device to the research team by post.
Data analysis
Quantitative data analysis will be conducted in three steps.
First, descriptive statistics will be used to describe demo-
graphic and clinical characteristics of the studied popula-
tion stratified by eligible consenting and non-consenting
participants, and screening, eligibility, consent and data
completion rates and reasons for excluding patients
reported as percentages. Second, intervention fidelity and
intervention adherence continuous data (e.g. number of
PA consultations, pedometer step count) will be presented
as means and standard deviation and categorical data (type
of consultation) as percentages. Third, assuming continu-
ous data outcomes, differences pre- and post-intervention
will be presented by the mean difference with the associ-
ated 95% confidence interval following t test analysis. This
is because the focus of the results from this feasibility study
will be on the estimates of treatment effects rather than
statistical significant and hypothesis testing, which is the
purpose of a full trial. Qualitative thematic analyses of
audio-recorded interviews will be conducted using the
Framework approach which is a rigorous method provid-
ing a structure within which qualitative data are organised
and coded and themes identified [33].
Ethical considerations
The research study has been approved by NHS North
East Scotland (REC reference 17/NS/0065); IRAS project
ID: 219548).
Fig. 1 Participant Flowchart
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Consent The ethical principles of ensuring freely given
fully informed consent and the right to withdraw from
research participation will apply. The right to anonymity
when reporting findings will be emphasised.
Confidentiality All participants will be informed that all
of the information that they provide to the research
team will remain confidential and will only be accessible
to members of that team. Only personal information that
is deemed vital for running this study will be obtained.
Participants will be given a unique study identifier so that
their name will be filtered out of any quantitative and
qualitative datasets used for analysis.
Participant risk The Association of Stoma Care Nurses
(ASCN) UK recommends core muscle exercises to
strengthen the abdominis in order to prevent parastomal
hernia formation. However, ASCN also advise against
lifting heavy objects since this may cause a parastomal
hernia [34]. The American College of Sports Medicine
roundtable on exercise guidelines for cancer survivors
recommends for people who have a stoma that (a)
physician-permission is obtained prior to participation
in contact sports, (b) special consideration be put in
place for swimming activities, (c) resistance programmes
should begin with low resistance and slow progression
and (d) flexibility programmes should pay particular
attention to maintaining correct breathing patterns in
order to avoid excessive intra-abdominal pressure [35].
We will ensure that all these recommendations are cov-
ered in the training programme for the instructors deliv-
ering the PA intervention in this feasibility study.
Safety reporting The adverse event reporting proce-
dures will follow those of NHS guidelines for research
trials. Reporting of adverse effects will be included in
participant diaries, and all participants will be advised
and encouraged to report concerns to the research team,
STUDY PERIOD
Enrolment Allocation Post-allocation* Trial end
TIMEPOINT -t1 0 t1 t2 t3 t4
…
t12
tx
ENROLMENT:
Eligibility screen X
Informed consent X
[Baseline data 
collection]
X
Allocation X
INTERVENTIONS:
[Physical activity]
ASSESSMENTS:
[Number of PA 
consultations, 
duration and type]
X X X X X
[Completion of 
prescribed physical 
activities]
X X X X X
[Pedometer step 
count]
X X X X X
[Study recruitment 
parameters e.g. 
consent, loss to follow 
up rate]
X
[Quality of life, 
fatigue, physical 
activity, systemic 
inflammation]
X X
*t1-t12 represents the 12 weeks of a physical activity intervention 
Fig. 2 SPIRIT figure of enrolments, interventions and assessments. Asterisk denotes that t1–t12 represents the 12 weeks of a physical
activity intervention
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their stoma nurse and their PA instructor. All serious
adverse events (SAE) and adverse events (AE) will be
recorded. Any SAE or AE will be reported, regardless of
considered link with intervention participation.
Data management
The study includes three paper report forms: researchers
in each site will complete a ‘recruitment form’ indicating if
a patient is eligible to participate and screened patient
clinical information (e.g. diagnosis); PA instructors will
complete a ‘consultation form’ indicating duration and
type of consultation; participants will complete a PA diary
(e.g., prescribed activities). Data on paper report forms will
be manually entered by a researcher into customised
password encrypted spreadsheets in Microsoft Excel. A
researcher will export data entered into Bristol Online
Survey to the Statistical Package for the Social Sciences
v19.0 for the purposes of analysis. All electronic data will
be retained on a university password-protected server, and
all paper records will be retained in a secure storage facil-
ity on university premises for a minimum of 10 years.
Discussion and dissemination
The findings from this feasibility study will be shared with
interested parties and audiences on a national and inter-
national level. The intention of this feasibility study is to
inform a full randomised control trial, and any outcomes
and findings from this preliminary work will be dissemi-
nated on that basis.
Evidence suggests that feasibility studies do not guarantee
success for the future trial and this is often due to poor
recruitment [36]. There are a range of contextual factors in-
fluencing the success of a trial (e.g. delays in study starting
due to research governance procedures, poor recruitment
due to poor buy-in from the clinical team) and wide vari-
ation between sites, which is why in the future full rando-
mised controlled trial there will be an internal pilot in all
sites [36].
We will present the study findings to the Big Bowel
Event which is organised by a UK research charity—
Bowel and Cancer Research. Participants at the Big
Bowel Event include patients with a stoma, clinicians
and researchers. The audience will help the research
team improve the intervention and study procedures in
preparation for a randomised controlled trial. A limita-
tion of this feasibility study is that we will not gather
data about the acceptability of randomisation. We will,
however, seek advice about what is the most acceptable
comparator arm in a future full trial for example, wait-
list control or usual care. A further limitation is that the
feasibility study will not provide indication of the sample
size needed for a future trial. We will seek advice at the
Big Bowel Event regarding what would be a meaningful
difference in outcomes between patients receiving a PA
intervention and those who do not from a patient
perspective and use their recommendation to estimate
the sample size needed for a future trial. We will inform
participants of the key findings if they agree to receive
this information. We will share information at relevant
conferences, and events of interest to the population
involved. We will also provide a lay summary of the trial
findings for public dissemination through charities,
support groups and other interested parties.
Study recruitment began in December 2017 and is cur-
rently ongoing.
To the best of our knowledge, this is the first PA inter-
vention study for patients with a stoma. There remains a
limited evidence base about PA in the stoma population.
Cross-sectional cohort studies highlight a trend toward
inactivity after stoma formation surgery and a fear of ex-
ercise in general [14, 15]. However, there have been no
PA intervention studies to date. This feasibility study
represents crucial preliminary work leading to a multi-
site, full randomised controlled trial.
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